Treatment of systemic lupus erythematosus and antiphospholipid syndrome: From experimental models to patients’ bedside

International Archives of Allergy and Immunology

Volumn 111, Issue 4, 1996, Pages 355-361

  Krause, Ilan ^a,b   Blank, Miri ^a,b   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid syndrome; Autoimmunity; Idiotypes; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; BROMOCRIPTINE; CIPROFLOXACIN; CYCLOSPORIN A; CYTOKINE; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; ROQUINIMEX; SEX HORMONE; THIAMAZOLE;

ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; EXPERIMENTAL MODEL; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029796523     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237392     Document Type: Article

References (51)

1. Thcofilopoulus AN, Dixon FJ: Murine models of systemic lupus erythematosus, Adv Immunol 1985;37:269-290.
2. Gutierrez-Ramos JC, Andrcu JL, Moreno Dc Alboran I: Insights into autoimmunity; from classical models to current perspectives, Immunol Reviews 1990; 118:73-101.
3. Andrews BS, Eisenberg RS, Theofilopoulos AN: Spontaneous murine lupus-like syndromes, Clinical and immunopatological manifestations in several strains, J Exp Med 1978; 148:1198-1215.
4. Portanova JP, Ebling FM, Hammond WS, Hahn BH, Kotzin BL: Allogeneic MHC antigen requirements for lupus-like autoantibodv production and nephritis in murine grafl-vs-host disease, J Immunol 1988:141:3370-3376.
5. Gharavi AE, Mellors RC, Elkon KB: IgG anti-cardiolipin antibodies in murine lupus, C'lin Exp Immunol 1989;78:233-238.
6. Smith HR, Hansen CL, Rose R, Canoso RT: Autoimmune MRL/lpr/lpr mice arc an animal model for the secondary antiphospholipid syndrome, J Rheumatol 1990:17:911-915.
7. Hashimoto Y, Kawamura M, Ichikawa K, Suzuki T, Suntida T, Yoshida S, Matsuura E, Ikehara S, Koike T: Antieardiolipin antibodies in NZWxBxSB FI mice: a model of antiphospholipid syndrome, J Immunol 1992:149: 1063-1069.
8. Mendlovic S, Brocke S, Shoenfeld Y, Bcn-Bas-sat M, Mcshorer A, Bakimer R, Mozes E: Induction of a systemic lupus erythematosus-likc disease in mice by a common human anti-DNA idiotype, Proc Natl Acad Sei USA 1988:85: 2260-2264.
9. Blank M, Mcndelovic S, Mozes E, Shoenfeld Y: Induction of SLE-like disease in naive mice with a monoclonal anti-DNA antibody derived from a patient with polymyositis carrying 16/6 Id, J Autoimmun 1988:1:683-689.
10. Tincani A, Balesterieri G, Allegri F, Cattaneo R, Fornasicri A, Sinico A, D'Amico G: Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16 6 idiotype, Clin Exp Rheumatol 1994;11:129-134.
11. Blank M, Krup M, Mcndelovic S, Ericke H, Mozes E, Talal N, Coates ARM, Shoenfeld Y: The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice, Scand.1 Immunol 1990:31:45-52.
12. Shoenfeld Y, Mozes E: Pathogenic idiotypes of antibodies and autoimmunity: Lessons from new experimental models of SLE, FASEB J 1990:4:2646-2651.
13. Rombach E, Stetler DA, Brown JC: Rabbits produce SLE-like anti-RNA polymerase I and anti-DNA autoantibodies in response to immunization with either human or murine SLE anti-DNA antibodies, Autoimmunity 1992; 13:291- 302.
14. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y: Induction of primary anti-phospholipid syndrome in mice by immunization with human monoclonal anti-cardioli-pin antibody (H-3), J Clin Invest 1992:89: 1558-1563.
15. Yodfat O, Blank M, Krause I, Shoenfeld Y: The pathogenic role of anti-phosphatidylserine antibodies: Active immunization with the antibodies leads to the induction of antiphospholipid syndrome, Clin Exp Immunol 1996;78:14-20.
16. Blank M, Krause I, Ben-Bassat M, Shoenfeld Y: Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype, J Autoimmunity 1992:5: 495-509.
17. Gharavi AE, Sammaritano LR, Wen J, Elkon KB: Induction of antiphospholipid antibodies by immunization with L glycoprotein I (apol-ipoprolein H), J Clin Invest 1992:90:1105- 1109.
18. Blank M, Fadin D, Tincani A, Kopolovic J, Goldberg I, Gilbrud B, Allegri F, Balestrieri G, Valesini G, Shoenfeld Y: Immunization with an-ticardiolipin cofactor (j)- glycoprotein D induces experimental anti-phospholipid syndrome in naive mice, J Autoimmun 1994;7:441 -455.
19. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal anti human polyclonal antieardiolipin antibodies, Proc Natl Acäd Sei USA 1991;88:3069-3073.
20. Branch DW, Dudley DJ, Mitchell MD, Creighton KA, Abbott TM, Hammond EH, Daynes RA: Immunoglobulin G fractions from patients with antiphospholipid antibodies causes fetal death in Balb/c mice: A model for autoimmune fetal loss, Am J Obstet Gynecol 1990:163:210-216.
21. Blank M, Mansoroi J, Tomer Y, Mansoroi A, Kopolovic J, Charcon-Polak S, Shoenfeld Y: Suppression of experimental systemic lupus erythematosus (SLE) with specific anti-idio-typic antibody-saporin conjugate, Clin Exp Immunol 1994;98:434-441.
22. Tomer Y, Blank M, Shoenfeld Y: Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies, Arthritis Rheumatol 1994:37:1236-1244.
23. Dweyer JM: Manipulating the immune system with immune globulin, N Engl J Med 1992:326: 107-116.
24. Krause I, Blank M, Kopolovic J, Afek A, Goldberg I, Tomer Y, Shoenfeld Y: Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin, J Rheumatol 1995:6:1068-1074.
25. Blank M, Ben-Bassat M, Shoenfeld Y: Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA idiotype, Cell Immunol 1991:137: 474-486.
26. Fishman P, Falach-Vakninc E, Zigelman R, Bakimer R, Sredni B, Djaldetti M, Shoenfeld Y: Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant intericukin-3, J Clin Invest 1993:91:1834-1837.
27. Blank M, Sercdni B, Albcck M, Mozes E, Shoenfeld Y: The effect of the immunomodula-tor agent AS 101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody, Clin Exp Immunol 1990:79:443-447.
28. Shoenfeld Y, Isenberg DA: The mosaic of autoimmunity, the factors associated with autoimmune diseases, Amsterdam, Elsevier, 1989.
29. Rubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK: Effect of castration and sex hormones treatment on survival, anti-nucleic acid antibodies and glomerulonephritis in NZB/ NZW FI mice, J Exp Med 1978:147:1568-1583.
30. Verlieul HA, Deckers GH, Schuurs AH: Effects of nandrolone decanoate or testosterone deca-noate on murine lupus: further evidence for a dissociation of autoimmunosuppressive and endocrine effects, Immunopharmacology 1986; 11:93-9.
31. Lahita RG, Kunkel HG: Treatment of systemic lupus erythematosus (SLE) with the androgen 19-nor-testosterone [abstract], Arthritis Rheumatol 1984:27 suppl: S65.
32. llazelton RA, MeC'rudcn AB, Sturrock RD, Stimson WH: Hormonal manipulation of the immune response in systemic lupus erythematosus: A drug trial of an anabolic steroid, 19-nortestosterone, Ann Rheum Dis 1983:42:155-157.
33. Blank M, Mendlovic S, Frickc H, Mozes E, Ta-lal N, Shoenfcld Y: Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idio-type in naive mice, J Rheumatol 1990:17:311-317.
34. Sthoeger ZM, Bcnlwich Z, Zinger I I, Mozes F.: The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus, J Rheumatol 1994:21:2231-2238.
35. Chan AC, Sack K: Danazol therapy for autoimmune hemolytic anemia associated with systemic lupus erythematosus (case report), J Rheumatol 1991:18:280-282.
36. Buskila D, Sukenic S, Shoenfeld Y: The possible role of prolactin in autoimmunitv, Am J Re-prod Immunol 1991;26:118-123.
37. Blank M, Krause I, Buskila D, Tcitelbaum D, Kopolovic J, Afek A, Goldberg I, Shoenfeld Y: Bromocriptine immunomodulation of experimental SLE and primary anti-phospholipid syndrome via induction of nonspecific T suppressor cells, Cell Immunol 1995:162:114-122.
38. Rabinovich CE, Schanbcrg LE, Kredich DVV: Intravenous immunoglobulin and bromocriptine in the treatment of refractory neuropsychiatric systemic lupus erythematosus, Arthritis Rheumatol 1990;33:R22.
39. McMurray RW, Wcidcnsaul D, Allen SIT, Walker SF.: Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus, J Rheumatol 1995:11:208-491.
40. Silvera III, Hubble CL, Jara LJ, Saway S, Mar-tincz-Osuma P, Seleznick MJ, Angel J, O’Brien W, Espinoza LR: Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin, Am J Med 1992:93:403-411.
41. Krause I, Blank M, Gilbrut B, Shoenfcld Y: The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome, Am.1 Re-prod Immunol 1993:29:155-161
42. Shoenfcld Y, Blank M: Effect of long-acting thromboxane receptor antagonist (BMS180,291) on experimental antiphospholipid syndrome, Lupus 1994:3:397-400.
43. Rosove MIL Tabsh K, Wassertrum N, Howard P, Hahn BH, Kalunian KC: Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies, Obslct Gynecol 1990;75:630-634.
44. Inbar O, Blank M, Faden D, Tmcani A, Lorber M, Shoenfcld Y: Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin, Am J Obstet Gynecol 1993:169:423-426.
45. Blank M, Ben-Bassat M, Shoenfeld Y: The effect of cyclosporin A on early and late stages of experimental lupus, Arthritis Rheum 1992:35: 1350-1355.
46. Kalland T: Regulation of natural killer progenitors Studies with novel immunomodulator with distinct effects at the precursor level. J Immunol 1990:144:4472- 4476.
47. Singer DS, Kohn LD, Zinger H, Mozes E: Mcthimazolc prevents induction of experimental systemic lupus erythematosus in mice, J Immunol 1994:153:873-880.
48. Kraussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A: Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation, J Immunol 1993:148: 1693-1698.
49. Blank M, Tomer Y, Slavin S, Shoenfcld Y: Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation, Scand J Immunol 1995:42:226-234.
50. Adachi Y, Inaba M, Antoh Y, Yoshifusa H, Nakamura Y, Suzuka H, Kamatu S, Nakai S, Haru-na H, Adachi M: Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice, Immunobiology 1995:192:218-230.
51. Fernandes G, Yunis E.I, Smith J, Good RA: Dietary influence on breeding behavior, hemolytic anemia, and longevity in NZB mice, Proc Soc Exp Biol Med 1972; 139:1189-1196.